Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis

2017 ◽  
Vol 107 (2) ◽  
pp. 235-243
Author(s):  
Yan Wang ◽  
Yuanming Xing ◽  
Lu Chen ◽  
Ti Meng ◽  
Ying Li ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Acute Lymphoblastic Leukemia ◽  
Clinical Outcome ◽  
Lymphoblastic Leukemia ◽  
Antifungal Prophylaxis ◽  
Cost Effectiveness Analysis ◽  
Adult Patients ◽  
Effectiveness Analysis

scholarly journals A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia

2018 ◽  
Vol 66 (1) ◽  
pp. e27458 ◽  
Author(s):  
Robin Q. H. Kloos ◽  
Raphaële R. L. van Litsenburg ◽  
Sarah Wolf ◽  
Leonoor Wismans ◽  
Gertjan J. L. Kaspers ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Acute Lymphoblastic Leukemia ◽  
Lymphoblastic Leukemia ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Erwinia Asparaginase
Sign in / Sign up

Export Citation Format

Share Document